Skip to main content
. 2018 Apr 13;9(28):19555–19568. doi: 10.18632/oncotarget.24656

Figure 2. TP53 and OSBPL10 mutations in DLBCL.

Figure 2

(A) Graphical view of TP53 and OSBPL10 mutations in the discovery cohort. (B) Graphical view of the TP53 and OSBPL10 mutations in the validation cohort. (C) Overview of detected mutations in the OSBPL10 exon 1 coding region.